Attitudes of pediatric gastroenterologists, rheumatologists and parents to vaccination based on an anonymous online survey

Differences in vaccination coverage among patients with IBD, JIA, and healthy children, as well as to identify differences in vaccination attitudes between parents and physicians, including barriers and facilitators of immunization were assessed. Vaccination coverage, reasons for refusal, trust in vaccines, and physician involvement in immunization were assessed. Statistical analysis was performed using Pearson’s χ² test and the MannWhitney test. Insufficient vaccination coverage among patients with IBD and JIA is influenced by both parental concerns and the cautious approach of specialists. The main barriers include medical exemptions, concerns about disease exacerbation, and inadequate coordination between primary care physicians and specialists. Improving vaccination coverage requires the development of personalized immunization strategies, interdisciplinary collaboration, and educational programs for both physicians and parents. To increase vaccination coverage, personalized immunization strategies, interdisciplinary collaboration, and educational programs for doctors and parents are needed.

1. Benchimol E.I., Tse F., Carroll M.W., et al. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD) – Part 1: Live Vaccines. Journal of the Canadian Association of Gastroenterology, 2021; 4(4): e59– e71. https://doi.org/10.1093/jcag/gwab015

2. Doran M.F., Crowson C.S., Pond G.R., O'Fallon W.M., Gabriel S.E. Predictors of infection in rheumatoid arthritis. Arthritis and Rheumatism, 2002; 46(9): 2294–2300. https://doi.org/10.1002/art.10529

3. Fleurier A., Pelatan C., Willot S., et al. Vaccination coverage of children with inflammatory bowel disease after an awareness campaign on the risk of infection. Digestive and Liver Disease, 2015; 47(6): 460–464. https://doi.org/10.1016/j.dld.2015.02.009

4. Jansen M.H.A., Rondaan C., Legger G.E., et al. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Annals of the Rheumatic Diseases, 2022. https://doi.org/10.1136/annrheumdis-2022-222574

5. Jansen M.H.A., Rondaan C., Legger G.E., et al. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Annals of the Rheumatic Diseases, 2023; 82(1): 35–47. https://doi.org/10.1136/annrheumdis-2022-222574

6. Kostik M.M., Lubimova N.A., Fridman I.V., Goleva O.V., Kharit S.M. The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study. Pediatric Rheumatology Online Journal, 2021; 19(1): 108. https://doi.org/10.1186/s12969-021-00594-2

7. Kucharzik T., Ellul P., Greuter T., et al. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. Journal of Crohn's and Colitis, 2021; 15(6): 879–913. https://doi.org/10.1093/ecco-jcc/jjab052

8. Lamb C.A., Kennedy N.A., Raine T., et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut, 2019; 68(Suppl 3): s1–s106. https://doi.org/10.1136/gutjnl-2019-318484

9. Lester R., Lu Y., Tung J. Survey of Immunization Practices in Patients With Inflammatory Bowel Disease Among Pediatric Gastroenterologists. Journal of Pediatric Gastroenterology and Nutrition, 2015; 61(1): 47–51. https://doi.org/10.1097/MPG.0000000000000730

10. Lichtenstein G.R., Feagan B.G., Cohen R.D., et al. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT registry. American Journal of Gastroenterology, 2012; 107(9): 1409–1422. https://doi.org/10.1038/ajg.2012.218

11. Martinelli M., Giugliano F.P., Strisciuglio C., et al. Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN. Inflammatory Bowel Diseases, 2020; 26(9): 1407–1414.

12. Morin M.P., Quach C., Fortin E., Chédeville G. Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre. Rheumatology (Oxford, England), 2012; 51(11): 2046–2050. https://doi.org/10.1093/rheumatology/kes175

13. Osterman M.T., Sandborn W.J., Colombel J.F., et al. Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab. American Journal of Gastroenterology, 2016; 111(12): 1806–1815. https://doi.org/10.1038/ajg.2016.433

14. Rahier J.F., Magro F., Abreu C., et al. Second European evidence-based consensus on the prevention, diagnosis, and management of opportunistic infections in inflammatory bowel disease. Journal of Crohn's and Colitis, 2014; 8(6): 443–468. https://doi.org/10.1016/j.crohns.2013.12.013

15. Toruner M., Loftus E.V. Jr., Harmsen W.S., et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology, 2008; 134(4): 929–936. https://doi.org/10.1053/j.gastro.2008.01.012

16. Zullow S., Farraye F.A. Updates on vaccinating the inflammatory bowel disease patient. Expert Review of Gastroenterology & Hepatology, 2019; 13(3): 229–239. https://doi.org/10.1080/17474124.2019.1565993